spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Vertex 

 HSMN NewsFeed - 6 Aug 2025
Mallinckrodt Names Christiana Stamoulis as President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2025
Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 May 2024
OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN)
Devices Orthopaedic FDA
 HSMN NewsFeed - 10 Apr 2024
TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Apr 2024
NeoImmuneTech Appoints Dr. Luke Oh, Ph.D. as New Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Jan 2024
NeoImmuneTech Welcomes a New President for its Development and Business
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Feb 2023
Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy
Biopharmaceuticals
 HSMN NewsFeed - 13 Jul 2022
Immunitas Therapeutics Appoints Lynette Herscha as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 May 2022
Odyssey Therapeutics Appoints Darryl Patrick, D.V.M., Ph.D., as Executive Vice President of Non-Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 May 2022
Odyssey Therapeutics Appoints Industry Leader Jeffrey M. Leiden, M.D., Ph.D., as Board Chair
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Sep 2021
Obsidian Therapeutics Announces Closing of $115 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Jun 2021
Senda Biosciences Strengthens Leadership Team with Key Management Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2021
Mineralys Therapeutics Closes $40 Million Series A Funding
Biopharmaceuticals Cardiology Venture Capital Personnel
 HSMN NewsFeed - 18 Nov 2020
Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 8 Jan 2020
Provention Bio Appoints Jason Hoitt as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jul 2019
Obsidian Therapeutics Announces Strengthening of Executive Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jul 2019
Proteostasis Therapeutics Announces Management Changes and Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jun 2019
SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2019
EIP Pharma Closes $11.2 Million Financing Round to Advance Development of Neflamapimod in Additional Neurodegenerative Disease Indications
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 11 Feb 2019
Nuvaira Announces a $79 Million Financing Round to Pursue Groundbreaking Treatment of COPD
Devices Venture Capital Personnel
 HSMN NewsFeed - 24 Jan 2019
Merck KGaA, Darmstadt, Germany, Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 May 2018
EIP Pharma Secures $20.5 Million in Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 5 Jun 2017
Bayer Expands Oncology Organization with Two New Leadership Team Appointments
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Apr 2017
Axovant Sciences Announces Appointment of Dr. David Hung as Chief Executive Officer and Expansion of Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Mar 2017
Moximed Closes Oversubscribed $50MM Financing Round
Devices Orthopaedic Venture Capital Personnel
 HSMN NewsFeed - 21 Feb 2017
Bristol-Myers Squibb Appoints Three New Independent Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2016
Moximed: First Patient Treated in US Study of Atlas(R) System for Unicompartmental Knee Osteoarthritis
Devices Orthopaedic
 HSMN NewsFeed - 19 Aug 2016
Bayer and CRISPR Therapeutics joint venture, named Casebia Therapeutics, establishes operations in Cambridge, MA
Biopharmaceuticals
 HSMN NewsFeed - 15 Jul 2016
Bach Pharma Appoints Kelly Blackburn as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Apr 2016
Enterome Raises EUR14.5 Million in Series C Financing Round
Biopharmaceuticals Gastroenterology Venture Capital
 HSMN NewsFeed - 2 Dec 2015
Kesios Therapeutics Raises £19 Million in Series A Financing
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 23 Nov 2015
Vertex Appoints Michael J. Parini as Executive Vice President and Chief Legal Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Nov 2015
Moximed Announces CE Mark and First Commercial Use of Atlas(TM) Knee System
Devices Orthopaedic Regulatory Product Launch
 HSMN NewsFeed - 10 Nov 2015
Seres Therapeutics Appoints Kurt Graves to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jul 2015
aTyr Pharma Announces Transitions In Clinical Development & Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2015
Cerulean Appoints Vice President, Clinical Operations
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 29 Oct 2014
Aileron Therapeutics Expands Senior Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Oct 2014
Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 23 Sep 2014
Ivantis Raises Additional $25 MM, Increasing Series B to $71 MM
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 6 Aug 2014
Akebia Therapeutics Announces Expansion of Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2014
Vertex Announces Retirement of Peter Mueller, Ph.D.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jun 2014
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor) in Eight Non-G551D Gating Mutations
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Apr 2014
Holaira Closes $42 Million Venture Financing Round
Devices Venture Capital Personnel
 HSMN NewsFeed - 18 Mar 2014
Immune Design Appoints Franklin M. Berger to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Mar 2014
Tetraphase Pharmaceuticals Adds Nancy J. Wysenski to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2014
Vertex Announces Appointment of Jeffrey A. Chodakewitz, M.D., as Chief Medical Officer and Senior Vice President of Global Medicines Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2013
Apricus Elects Kleanthis G. Xanthopoulos, Ph.D. as New Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Nov 2013
Vertex Sells INCIVO(R) Product Royalty Rights for $152 Million
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 2 Jul 2013
Warp Drive Bio Appoints Co-Founder Gregory Verdine, Ph.D., to Chief Executive Officer; Expands Team with Two Key Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2013
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personalized Medicine Personnel
 HSMN NewsFeed - 4 Sep 2012
Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2012
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2012
EMD Serono, Inc. Strengthens Leadership Teams with New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2012
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Jun 2011
Nimbus Discovery Secures $24 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 23 May 2011
FDA Approves INCIVEK(TM) (telaprevir) for People with Hepatitis C
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Mar 2011
Medtronic Introduces VERTEX SELECT(R) CHROMALOY(TM) Plus Rods
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 27 Jan 2011
Medtronic Announces Global Launch of the CD HORIZON(R) SOLERA(TM) Spinal System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 19 Jan 2011
James E. Shipley, M.D., Named Chief Medical Officer of Concert Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Oct 2010
Medtronic Introduces the VERTEX SELECT(R) Reconstruction System Posted Screw Module
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 10 Aug 2010
Phase 3 ILLUMINATE Study Supports 24-Week Telaprevir-Based Therapy Within a Response-Guided Regimen for People with Hepatitis C Who Had Not Received Prior Treatment
Biopharmaceuticals
 HSMN NewsFeed - 25 May 2010
Dr. John Mendlein Joins aTyr Pharma as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2010
Medtronic Introduces the VERTEX SELECT(R) Reconstruction System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 12 Jan 2010
Eric Ruby Joins Presidio Pharmaceuticals, Inc. as Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2010
Constellation Pharmaceuticals Appoints Kerry K. Reinertsen, Ph.D. as Company's Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2009
Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2009
Dennis Winger Joins Nektar Therapeutics' Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Dec 2009
Vertex Pharmaceuticals Announces Appointment of Nancy J. Wysenski as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2009
Accuray Announces Additions to Board of Directors
Devices Oncology Personnel
 HSMN NewsFeed - 30 Oct 2008
Alnara Pharmaceuticals, Inc. Secures $20 Million in Series A Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jun 2008
Vertex Pharmaceuticals Announces the Appointment of Freda C. Lewis-Hall, M.D., as Executive Vice President, Medicines Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2008
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2008
CoNCERT Pharmaceuticals Announces Appointment of Justine Koenigsberg as Senior Director, Corporate Communications and Investor Relations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2008
Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2008
Advanced Medical Optics Enters into Phacoemulsification Patent Agreement with Bausch & Lomb
Devices Ophthalmology
 HSMN NewsFeed - 3 Dec 2007
Regulus Therapeutics Appoints Kleanthis G. Xanthopoulos, Ph.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Nov 2007
Vertex's Collaborator Merck Suspends Patient Enrollment in Clinical Trials of MK-0457 (VX-680) Pending Full Analysis of Clinical Data
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Nov 2007
First Studies Demonstrating Greater than Sixty Percent Sustained Viral Response Rates with Half the Standard Treatment Duration in Genotype 1 Chronic Hepatitis C Patients
Biopharmaceuticals
 HSMN NewsFeed - 27 Sep 2007
Medtronic Will Appeal Jury Verdict
Devices Orthopaedic, Neurosurgery Litigation
 HSMN NewsFeed - 4 Sep 2007
Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jul 2007
New Head-to-Head Study Comparing LEXIVA(R) and Atazanavir Show Similar Efficacy and Lipid Changes
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 29 Jun 2007
Vertex Pharmaceuticals Announces Two Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2007
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 May 2007
Mersana Therapeutics, Inc. Announces the Appointment of Robert J. Fram, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Mar 2007
Biomet Announces Federal Circuit Ruling in Its Lawsuit against Medtronic Sofamor Danek
Devices Orthopaedic Litigation
 HSMN NewsFeed - 20 Mar 2007
Medtronic Wins Appeal in Patent Dispute with Biomet
Devices Litigation Orthopaedic Neurosurgery
 HSMN NewsFeed - 30 Nov 2006
Concert Pharmaceuticals Raises $48.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Nov 2006
Medtronic Wins Appeals Court Ruling on Largest Pedicle Screw Lines
Devices Orthopaedic Neurosurgery Litigation
 HSMN NewsFeed - 25 Oct 2006
Caprion Pharmaceuticals Announces Expansion of Biomarker Discovery Collaboration with Vertex Pharmaceuticals
Biopharmaceuticals
 HSMN NewsFeed - 28 Sep 2006
GlaxoSmithKline and Vertex Pharmaceuticals Announce Virologic and Drug Resistance Results from Protease Inhibitor Study
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 17 Jul 2006
Concert Pharmaceuticals, Inc., a Small Molecule Pharmaceutical Company, Announces Financing of its Series A Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jun 2006
Vertex Pharmaceuticals and Janssen Pharmaceutica, a Johnson & Johnson Company, Form Collaboration to Develop and Commercialize VX-950 for Treatment of Hepatitis C
Biopharmaceuticals
 HSMN NewsFeed - 1 Jun 2006
Ablynx Strengthens Management Team - Eva-Lotta Allan Joins as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 May 2006
Vertex Pharmaceuticals Initiates the First of Two Major Phase II Studies of VX-950 in Treatment-Naive HCV Patients
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2006
Researchers Report Results for 28-day Phase II Study of VX-950 in Combination with Pegylated Interferon and Ribavirin in Hepatitis C Patients
Biopharmaceuticals
 HSMN NewsFeed - 16 May 2006
GlaxoSmithKline and Vertex Pharmaceuticals Announce Preliminary 48-Week Results from Head-to-Head Clinical Study of HIV Protease Inhibitors Lexiva (Telzir) and Kaletra in Treatment-naive Patients with HIV
Biopharmaceuticals HIV/AIDS
Return to NewsFeed  

 Additional items found! 79

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 79 additional stories matching:
Vertex
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!